Director Coverage & Case Sign Out

Dr. Aurelia Meloni-Ehrig and Dr. Zunyan Dai have extensive knowledge in cytogenetics and molecular genetics, combined with their leadership experience at well-respected organizations such as CSI Laboratories, Emory Genetics Laboratory, AmeriPath, Quest Diagnostics, University of Utah, and Genetrix , make them uniquely qualified to offer flexible laboratory director coverage and case sign out services.

Short-Term and Long-Term Solutions for Your Staffing Needs

Whether your organization requires occasional coverage due to a short-term illness or staffing shortage, or interim laboratory director coverage during an ongoing search, you can count on erGenetics to provide the assistance you need to prevent backlogs and ensure efficient operations:

• Flexible laboratory direct coverage
• Interpret and sign out prenatal, postnatal, and oncology cytogenetic and FISH reports
• Computer-assisted case report sign out for overflow cases
• Interpretation and Case Sign Out:
  1. Cytogenetic: oncology (leukemia, lymphoma, solid tumors), prenatal and postnatal
  2. FISH: oncology, prenatal, and postnatal
  3. Microarray: oncology, prenatal, and postnatal, and molecular microarrays
  4. Molecular genetics: non-sequencing assays, Sanger sequencing, next-generation sequencing (NGS)
  5. Molecular oncology
• Remote services via erGenetics’ CLIA-certified laboratory

Dr. Meloni-Ehrig is board certified in clinical cytogenetics by the American Board of Medical Genetics and Genomics (ABMGG) and a fellow of the American College of Medical Genetics (ACMG). Learn more about her experience.

At erGenetics, our goal is to exceed your expectations. To inquire about our director coverage and case sign out services, please call our office at 540 878-8276 or contact us online. We look forward to speaking with you and appreciate the opportunity to partner with your organization.